GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,866.50p
   
  • Change Today:
      5.00p
  • 52 Week High: 2,208.00p
  • 52 Week Low: 1,442.50p
  • Currency: UK Pounds
  • Shares Issued: 4,045.42m
  • Volume: 4,089,615
  • Market Cap: £75,508m
  • RiskGrade: 129
  • Beta: 0.00

GSK Overview

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 3.4% 0.0%
Div Cover 2.6 n/a
Op Mrgn 24.3% n/a
ROCE 62.0%  
Latest F'cast
P/E 11.4 n/a
PEG 1.4 n/a
Pr/Revenue 2.4 n/a
Pr/Book 5.0  
Latest F'cast
Revenue 4.1% n/a
PBT 112.9% n/a
EPS 8.0% n/a
DPS 8.2% n/a

GSK Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 24,696.00 3,599.00 90.56p 22.2 n/a -22% 80.00p 4.0%
31-Dec-22 29,324.00 5,628.00 139.70p 10.3 0.2 +54% 44.00p 3.1%
31-Dec-23 30,328.00 6,064.00 155.10p 9.4 0.9 +11% 58.00p 4.0%
31-Dec-24 31,376.00 3,477.00 159.30p 8.5 2.8 +3% 61.00p 4.5%
31-Dec-25 32,667.00 7,401.00 172.00p 10.6 1.3 +8% 66.00p 3.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GSK Company Announcements

Total Voting Rights 01-Sep-2026 15:00 RNS
mRNA flu vaccine candidate to advance to phase III 01-Sep-2026 07:00 RNS
Director/PDMR Shareholding 26-Aug-2026 15:30 RNS

GSK ShareCast News

GSK advances mRNA flu shot after Phase II success 01-Sep-2026 ShareCast
GSK notches major regulatory milestones in Japan... 24-Aug-2026 ShareCast
GSK launches £2bn cost savings drive, confirms n... 28-Jul-2026 ShareCast

GSK Top Newspaper Links

GSK invests £400m to relocate research headquart... 28-Jul-2026 Times
GSK to buy US cancer treatment firm Nuvalent for... 09-Jun-2026 Guardian
GSK signs £45m deal with UCL offshoot for liver ... 08-Jun-2026 Times

Latest GSK Director Deals

Traded Action Notifier PriceAmountValue
11-Aug-26 Transfer From Julie Brown 0.000p 7 £0.00
11-Aug-26 Buy Julie Brown 1,934.96p 7 £135.45
10-Jul-26 Buy Dividends Vishal Sikka 1,968.32p 218 £4,290.94

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GSK Market Data

Currency UK Pounds
Share Price 1,866.50p
Change Today 5.00p
% Change 0.27 %
52 Week High 2,208.00p
52 Week Low 1,442.50p
Volume 4,089,615
Shares Issued 4,045.42m
Market Cap £75,508m
Beta 0.00
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average6.98% above the market average
36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average36.36% above the sector average
Income Not Available
Growth Not Available

GSK Dividends

  Latest Previous
  Q2 Q1
Ex-Div 13-Aug-26 14-May-26
Paid 08-Oct-26 09-Jul-26
Amount 17.00p 17.00p

Trades for 03-Sep-2026

Time Volume / Share Price
18:14 9 @ 1,887.03p
16:39 100 @ 1,866.50p
16:36 2,308 @ 1,866.50p
16:36 2,308 @ 1,866.50p
16:36 2,308 @ 1,866.50p

GSK Key Personnel

CEO Luke Miels

Top of Page